310417
4-(溴甲基)苯乙酸
95%
登录查看公司和协议定价
选择尺寸
关于此项目
线性分子式:
BrCH2C6H4CH2CO2H
化学文摘社编号:
分子量:
229.07
Beilstein:
2360711
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:
NACRES:
NA.22
方案
95%
表单
solid
mp
179-183 °C (lit.)
SMILES字符串
OC(=O)Cc1ccc(CBr)cc1
InChI
1S/C9H9BrO2/c10-6-8-3-1-7(2-4-8)5-9(11)12/h1-4H,5-6H2,(H,11,12)
InChI key
WCOCCXZFEJGHTC-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
应用
丝氨酸蛋白酶抑制剂的前体。用于合成新型冠醚受体。
警示用语：
Danger
危险分类
Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
法规信息
新产品
此项目有
R Rai et al.
Journal of medicinal chemistry, 35(23), 4297-4305 (1992-11-13)
Previously, we have reported that some guanidino-substituted alpha- and beta-aryl enol lactones I and II behaved as selective, mechanism-based inhibitors of some trypsin-like proteases (Rai, R.; Katzenellenbogen, J.A. J. Med. Chem., submitted). In this study, we describe the synthesis and
Journal of the Chemical Society. Chemical Communications, 399-399 (1993)
Zhiqiang Feng et al.
Bioorganic & medicinal chemistry letters, 19(8), 2270-2272 (2009-03-17)
We have developed a novel and moderately selective COX-2 inhibitor, imrecoxib, as a new anti-inflammatory drug. We describe herein the preparation of the major metabolites M2 and M4 of imrecoxib, as well as the in vitro and in vivo activities
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持